col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


10 Results       Page 1

 [1] 
Mary Ann Liebert: Biotechnology Law Report
  original article Date Title Authors   All Authors
1 [GO] 2023―Sep―26 Observation on China's Performance in the Global Supply Chain of COVID-19 Medicine NA LI, YUPENG DONG, XIANG YU
2 [GO] 2023―May―24 The Legislative Paradigm of China's Biosafety Law and Its Positive Significance for the SARS-CoV-2 Prevention and Control Zhou Chen, Wu Wanqiang
3 [GO] 2023―Feb―02 Observation on the R&D Effectiveness and Application of China's Novel Coronavirus Vaccine Xiang Yu, Na Li, Hui Wang
4 [GO] 2022―Jun―07 China's Challenges in Implementing Compulsory Drug Patent Licenses and its Response in the Context of COVID-19 PENG FEIRONG, MAO TIAN, CHEN JUNHUA
5 [GO] 2022―Jun―06 Regulation of Clinical Trials and Pandemic Research: Upholding Ethical Standards During a COVID-19 Crisis Patrick Foong, Grace Borsellino
6 [GO] 2022―Mar―25 Patents Cannot Be Blamed for Inequitable Access to COVID-19 Vaccines RAILDO DUARTE, HASAN IRFAN KHAN, ALEJANDRO LUNA, RAMADAN AMIN, CHARUL YADAV, ULRICH STORZ
7 [GO] 2021―Mar―11 The Compulsory Licensing for Exploiting Patented COVID-19 Pharmaceutical Treatment: Legal Approaches of Some Arab Countries Tariq Kameel, Ramzi Madi, Kawthar Kayed
8 [GO] 2020―Nov―23 Amendment of China's Biotechnology Laws in Relation to the Prevention and Containment of the COVID-19 Pandemic Zi Zhengfa, Wu Wanqiang
9 [GO] 2020―Sep―28 UK Biotech Corporate Finance Trends Post COVID-19 Sunjay Malhotra, Julian Stanier
10 [GO] 2020―May―08 Continuing CRISPR Patent Disputes May Be Usurped by Its Potential Role in Fighting Global Pandemics Asawari Churi, Sarah Taylor
 [1] 

10 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.003 sec